Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine vs Ropivacaine in Lower Limb Bypass Surgery
NCT06677697Phase 4Completed
- Sponsor
- Ibrahim Cardiac Hospital and Research Institute
- Start
- Jan 2021
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in lower extremity injury, sponsored by Ibrahim Cardiac Hospital and Research Institute. Started Jan 2021; status: completed.
02
Drugs
ropivacaine
03
Conditions
lower extremity injury
Beyond the preview
Go deeper on NCT06677697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06677697.